炎症状态对伏立康唑血药浓度影响的系统综述
本系统综述纳入20项研究,评估炎症状态对伏立康唑(VRZ)水平的影响。结论认为炎症水平可显著影响VRZ水平,临床医生调整VRZ剂量时应考虑患者炎症状态,但儿童中该影响存在争议且需结合年龄分析。
要点
- 炎症水平可显著影响伏立康唑血药浓度。
- 临床调整伏立康唑剂量时应考虑患者炎症状态。
- 儿童中炎症对伏立康唑浓度的影响存在争议,需结合年龄分析。
核心结论
- 炎症水平可显著影响伏立康唑(VRZ)水平。
- 临床医生调整VRZ剂量时应考虑患者炎症状态。
- 儿童中炎症对VRZ浓度的影响存在争议,必须结合年龄分析。
- 炎症对基于基因型的剂量决策的影响需进一步研究。
研究设计与样本
- 系统综述,纳入随机临床试验、队列研究和病例对照研究。
- 遵循PRISMA指南,检索PubMed、Embase、Web of Science和Cochrane Library截至2021年的相关文献。
- 共纳入20项研究,其中15项为成人人群,3项为儿科人群,2项同时包含成人和儿科人群。
主要发现
- 6项研究描述了CRP代表的炎症对VRZ浓度的剂量反应关系。
- 4项研究考察了CRP对VRZ代谢率的影响。
临床怎么用
- 临床医生在给伏立康唑 dosing 时应考虑患者的炎症状态。
- 儿童患者中炎症对伏立康唑浓度的影响需结合年龄分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study aimed to review the studies evaluating the effect of the inflammatory state on voriconazole (VRZ) levels. METHODS: The study included randomized clinical trials, cohort studies, and case-control studies that focused on the influence of the inflammatory state on VRZ levels. Following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, relevant articles published until 2021 were searched in several databases, including PubMed, Embase, Web of Science and the Cochrane Library. RESULTS: Twenty studies were included in this review, of which 15 described adult populations, three described paediatric populations, and two included both adult and paediatric populations. Seventeen studies used C-reactive protein (CRP) as an indicator of inflammation, six described a dose-response relationship for the effect of inflammation represented by CRP on VRZ concentrations, and four examined the effect of CRP on the metabolic rate of VRZ. CONCLUSIONS: Our findings showed that the level of inflammation can significantly affect VRZ levels. However, the effect of inflammation on VRZ concentrations in children is controversial and must be analysed along with age. Clinicians dosing VRZ should take into account the patient's inflammatory state. The impact of inflammation on genotype-based dosing decisions requires further study to explain the high pharmacokinetic variability of VRZ.
引用
- Li X, Lai F, Jiang Z, et al. Effects of inflammation on voriconazole levels: A systematic review. Br J Clin Pharmacol. 2022. PMID: 35973037. doi:10.1111/bcp.15495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。